(NULG) Nuveen ESG Large-Cap Growth - Overview
Etf: Technology, Consumer, Healthcare
Dividends
| Dividend Yield | 0.12% |
| Yield on Cost 5y | 0.20% |
| Yield CAGR 5y | -57.75% |
| Payout Consistency | 71.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.3% |
| Relative Tail Risk | 4.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.31 |
| Alpha | -7.24 |
| Character TTM | |
|---|---|
| Beta | 1.108 |
| Beta Downside | 1.024 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.28% |
| CAGR/Max DD | 0.97 |
Description: NULG Nuveen ESG Large-Cap Growth January 16, 2026
Nuveen ESG Large-Cap Growth ETF (BATS:NULG) seeks to track an index of U.S. large-cap equities that satisfy defined environmental, social, and governance (ESG) screens, allocating at least 80 % of its net assets (plus any borrowings) to the index constituents.
As of the most recent filing, NULG carries an expense ratio of 0.31 % and manages roughly $1.2 billion in assets, with the top five holdings-Apple, Microsoft, Amazon, Alphabet, and Nvidia-accounting for about 25 % of the portfolio, reflecting a heavy tilt toward technology and consumer-discretionary sectors.
Key drivers of performance include: (1) continued corporate earnings growth in the tech sector, which historically outperforms during periods of low-interest rates; (2) rising investor demand for ESG-aligned products, which can boost liquidity and price premiums for qualifying stocks; and (3) macro-economic trends such as U.S. GDP growth and inflation expectations that influence valuation multiples for growth-oriented companies.
For a deeper, data-rich analysis of NULG’s risk-adjusted returns and ESG scoring methodology, you might explore the ValueRay platform to complement your due-diligence.
What is the price of NULG shares?
Over the past week, the price has changed by -1.85%, over one month by -3.78%, over three months by -1.41% and over the past year by +8.92%.
Is NULG a buy, sell or hold?
What are the forecasts/targets for the NULG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 110.6 | 15.1% |
NULG Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.28b USD (2.28b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.28b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.28b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.0% (E(2.28b)/V(2.28b) * Re(10.0%) + (debt-free company))
Discount Rate = 10.0% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)